MEGACEP_Prospective Phase II Study Evaluating a Multimodal Care of Inguinal Node Metastasis in Squamous Cell Carcinoma of the Penis by Bilateral Lymphadenectomy and Chemotherapy TIP

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512827-36-00

Acronym

UC_0160/1406

Enrollment

Registered

2024-05-14

Start date

2016-10-17

Completion date

Unknown

Last updated

2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Penis carcinoma

Brief summary

Survival without locoregional lymph node recurrence [ Time Frame: 24 months ] checked by inguinal ultrasound

Interventions

DRUGDEXCHLORPHENIRAMINE MALEATE

DRUGIFOSFAMIDE

DRUGCISPLATIN

DRUGPACLITAXEL

DRUGMETHYLPREDNISOLONE

DRUGRANITIDINE

DRUGMESNA

DRUGAPREPITANT

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Survival without locoregional lymph node recurrence [ Time Frame: 24 months ] checked by inguinal ultrasound	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026